GlassScriptPhysician profile
Joseph R Deily
NPI 1952337636
$52,425.42
in general payments reported to CMS, 2019-2025
13 companies · $734 in 2025
The $734 reported for 2025 was more than what 86% of Surgical providers received nationally (typical 2025 total: $146).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $8,548 · 2022: $15K · 2023: $20K · 2024: $7,845 · 2025: $734.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $19K · Travel and Lodging: $6,214 · Food and Beverage: $3,173.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $19,000.00 |
| Travel and Lodging | $6,214.02 |
| Food and Beverage | $3,172.73 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Atricure, INC. | $42,380.72 | 2021-2025 | Atricure Cryoice Cryosphere Cryoablation System, Atriclip Laa Exclusion System, Synergy Ablation System |
| Haemonetics Corporation | $7,010.63 | 2023-2025 | Teg6s Hemostasis System, Haemonetics Cell Saver Elite+ System |
| Medtronic, INC. | $1,372.32 | 2021-2025 | Corevalve Evolut R, Intellis Adaptivestim, Venaseal |
| Getinge USA Sales, LLC | $496.09 | 2022-2024 | Heartstring III Proximal Seal |
| Medical Device Business Services, INC. | $220.44 | 2021-2024 | Ethicon |
| Abiomed | $204.29 | 2021-2023 | Impella |
| Stryker Corporation | $169.58 | 2024-2025 | Stryker Varispeed, Universal Neuro 2, Na |
| Solventum Corporation | $135.74 | 2024 | Prevena |
| Idorsia Pharmaceuticals US INC | $124.98 | 2023 | Quviviq |
| Edwards Lifesciences Corporation | $120.43 | 2024 | Konect Resilia |
| Angiodynamics, INC. | $108.70 | 2021 | |
| Lsi Solutions INC | $59.16 | 2025 | Cor-Knot |
| Cardiva Medical, INC. | $22.34 | 2025 | Cardiva Vascade 6/7f Vcs |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Joseph Deily listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.